Showing results (31-40 of 374) with videos related to
Sort By:
Pageof 38
Science (New York, N.Y.)|November 15, 1974
Hycanthone analogs: dissociation of mutagenic effects from antischistosomal effectsP B Hulbert, E Bueding, P E HartmanJournal of Medicinal Chemistry|July 1, 1977
Differences in antischistosomal and mutagenic properties between an isothiocyano- and an isocyanonitrodiphenylamineA W Coulter, E Bueding, R P BatzingerCancer Research|December 1, 1978
Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agentsR P Batzinger, S Y Ou, E BuedingProceedings of the National Academy of Sciences of the United States of America|April 1, 1988
N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylaminesD M Ziegler, S S Ansher, T Nagata, et al.International Journal of Technology Assessment in Health Care|January 13, 2001
A note on QALYs versus HYEs. Health states versus health profilesP DolanJournal of Health Services Research & Policy|May 2, 2000
Effect of age on health state valuationsP DolanPharmacoeconomics|June 3, 1999
Valuing health-related quality of life. Issues and controversiesP DolanMedical Decision Making : an International Journal of the Society for Medical Decision Making|October 16, 1999
Whose preferences count?P DolanHealth Policy (Amsterdam, Netherlands)|November 3, 1996
Modelling valuations for health states: the effect of durationP DolanPageof 38